- Project Summary
- Study Duration
- Objectives
- Outcomes
- Team Members
- Publications
Project Summary
Children’s Lung Study in Dhulikhel, Nepal (C-LUNG) – Childhood LRTIs are still the most common cause of hospitalizations in children globally among the leading causes of under 5 child deaths (U5D), contributing to an estimated 740,000 annual deaths. Nepal is in the high incidence and high mortality group for LRTIs globally. A recent WHO consensus emphasizes knowledge and implementation gaps related to changing epidemiology towards more viral and less bacterial cases. Therefore, this study aims to establish the viral etiology, immunological profile and its outcome, an observational cohort study will be carried out.
Study Duration
From October 2023 to December 2026
Objectives
To investigate the association between viral causes, immune system dysfunctions, and environmental hazards in the development of chronic lung diseases among children.
Outcomes
During the clinical evaluation, the children will have access to a specialized lung function test using CE marked Exhalyzer D. Additionally, during enrollment, readmissions, and follow-ups (telephonic and in person), the parents will be made aware of the signs of the well-being of their children. Additionally, the children (infected and healthy) will undergo free health checkups, be evaluated for lung function tests, and identification of asymptomatic/symptomatic viral infections. Moreover, the children will be provided with extra care from the consultant pediatrician. Additionally, we expect to identify viral etiologies behind LRI in children (RSV, hMPV, Influenzavirus, and SARSCOV-2), including specific clinical and outcome patterns for these viruses in the specific setting, indicating risk factors from short and long-term complications.
These may, in turn, guide future vaccination guidelines and renewed indications for antibiotic treatment. We also expect to identify immune dysregulation and environmental factors that interact in the development of chronic lung disease (CLD). Through the results of the study will be able to differentiate between infected and non-infected individuals based on immunological profiles. This study will also build capacity for the investigation of respiratory infections and immunological profiles associated with children’s lung infections as well as epidemic/pandemic capacity related to upgraded viral qPCR lab, methods, and competence. Finally, this is a first-of-its-kind integrated and novel study, in Nepal, to identify etiologies of viral infection and immunological in the pediatric population. The findings of this study overall drive the current diagnostic protocol and vaccination strategies.
Team Members
Co-Principal Investigator(s):Â Prof. Dr. Rajeev Shrestha, Prof. Dr. Kari R. Risnes, Prof. Dr. Srijana Dongol, Prof. Dr. Trude Helen Flo
Co-Investigator(s): Dr. Biraj Man Karmacharya, Dr. Dipesh Tamrakar, Mr. Nishan Katuwal
Project Manager(s): Mr. Nishan Katuwal
Project Coordinator(s): Dr. Renu Shahi, Mr. Sabin Bikram Shahi
Field Coordinator (s): Mr. Suman Shrestha
Research Assistant(s): Ms. Sarita Gosain, Ms. Sonisha Dumaru, Ms. Anita Shahi, Ms. Reena Kharbuja
Supported by: Research Council of Norway, Norway
Collaborating Partners: Norwegian University of Science and Technology (NTNU), Norway; Molde Hospital, Molde, Norway.
Publications
1. Verwey, C., Dongol, S., Shahi, R., Islam, MS., Katuwal, N., Haug, M., Flo, TH., Shrestha, R., Risnes, R. Pulmonary Function Testing using Tidal Breath Flow-Volume Loops in Healthy Children 1-24 months of age in semi-rural Nepal: Feasibility Study. Pediatric Pulmonology. 2026. 61 (2). e71518. https://doi.org/10.1002/ppul.71518Â











